HLA-DR/DQ eplet mismatch predicts de novo donor-specific antibody development in multi-ethnic Southeast Asian kidney transplant recipients on different immunosuppression regimens

被引:1
|
作者
Wong, Emmett Tsz Yeung [1 ,2 ,3 ]
Pochinco, Denise [4 ]
Vathsala, Anantharaman [1 ,2 ]
Koh, Wee Kun [2 ]
Lim, Amy [2 ]
Sran, Hersharan Kaur [1 ,2 ]
D'Costa, Matthew Ross [2 ]
Chang, Zi Yun [2 ]
Nickerson, Peter W. [3 ,4 ,5 ]
Wiebe, Chris [3 ,4 ,5 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[2] Natl Univ Singapore Hosp, Natl Univ Ctr Organ Transplantat, Singapore, Singapore
[3] Univ Manitoba, Dept Med, Winnipeg, MB, Canada
[4] Shared Hlth Serv Manitoba, Winnipeg, MB, Canada
[5] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada
关键词
human leukocyte antigen; histocompatibility; molecular mismatch; eplets; kidney transplant; donor-specific antibodies; MEDIATED REJECTION; EPITOPE-MISMATCH; FAILURE; RISK;
D O I
10.3389/fgene.2024.1447141
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Eplet mismatch has been recognized as a more precise strategy for determining HLA compatibility by analyzing donor-recipient HLA differences at the molecular level. However, predicting post-transplant alloimmunity using single-molecule eplet mismatch categories has not been validated in Asian cohorts. We examined a cohort of Southeast Asian kidney transplant recipients (n = 234) to evaluate HLA-DR/DQ eplet mismatch as a predictor of de novo donor-specific antibody (dnDSA) development. HLA-DR/DQ single-molecule eplet mismatch was quantified using HLA Matchmaker, and we utilized previously published HLA-DR/DQ eplet mismatch thresholds to categorize recipients into alloimmune risk groups and evaluate their association with dnDSA development. Recognizing that the predominance of cyclosporine use (71%) may alter published eplet mismatch thresholds derived from a largely tacrolimus-based (87%) cohort, we evaluated cohort-specific thresholds for HLA-DR/DQ single-molecule eplet mismatch categories. Recipient ethnicities included Chinese (65%), Malays (17%), Indians (14%), and others (4%). HLA-DR/DQ dnDSA developed in 29/234 (12%) recipients after a median follow-up of 5.4 years, including against isolated HLA-DR (n = 7), isolated HLA-DQ (n = 11), or both (n = 11). HLA-DR/DQ single-molecule eplet mismatch risk categories correlated with dnDSA-free survival (p = 0.001) with low-risk recipients having a dnDSA prevalence of 1% over 5 years. The cohort-specific alloimmune risk categories improved correlation with HLA-DR/DQ dnDSA-free survival and remained significant after adjusting for calcineurin inhibitor and anti-metabolite immunosuppression (p < 0.001). We validated the performance of single-molecule eplet mismatch categories as a prognostic biomarker for HLA-DR/DQ dnDSA development in a cohort of predominantly Asian kidney transplant recipients after adjusting for different immunosuppression regimens.
引用
收藏
页数:9
相关论文
共 43 条
  • [21] Impact of De Novo Donor-Specific Antibody (DSA) to HLA-DQ Alone in Pediatric Renal Transplant Recipients.
    Smith, J.
    Nelson, K.
    Warner, P.
    Finn, L.
    Pope, H.
    McDonald, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 508 - 508
  • [22] Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody?
    Wen, Jiqiu
    Basu, Arpita
    Bentall, Andrew
    Henderson, Nicole
    Dukek, Brian
    Gandhi, Manish
    Schinstock, Carrie
    HUMAN IMMUNOLOGY, 2021, 82 (04) : 240 - 246
  • [23] Role of ExPlex HLA antibody panel in de novo HLA donor-specific antibody identification in kidney transplant recipients: 2 case reports
    Kendrick, J.
    Murrin, M.
    Dzion, J.
    Garabiles, E.
    Hardage, B.
    McCall, A.
    Patel, P.
    Robinson, Y.
    Santiago, R.
    Boasi, R.
    Williams, C.
    Du, Z.
    Elrefaei, M.
    HUMAN IMMUNOLOGY, 2023, 84 : 115 - 115
  • [24] Hla-dq Epitope Mismatch Predicts De Novo Donor-Specific Antibody Formation and Acute Cellular Rejection After Living Donor Liver Transplantation
    Ono, K.
    Ide, K.
    Tanaka, Y.
    Ohira, M.
    Tahara, H.
    Tanimine, N.
    Akimoto, S.
    Imaoka, Y.
    Sato, K.
    Yamane, H.
    Tsukiyama, N.
    Ide, R.
    Mochizuki, T.
    Ohdan, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 577 - 577
  • [25] Association Between Induction Immunosuppression and De Novo Donor-Specific Hla Antibody Production in Combined Kidney and Pancreas Transplant Recipients: A Single-Center Experience
    Mumtaz, S.
    Jarmi, T.
    Ruiz, A.
    Li, Z.
    Elrefaei, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S836 - S836
  • [26] CLASS II HLA EPLET MISMATCH IS RELATED TO ANTI-DONOR CD4+T CELL RESPONSE AND DE NOVO DONOR-SPECIFIC ANTIBODY DEVELOPMENT IN KIDNEY TRANSPLANTATION RECIPIENT
    Tanaka, Hiroaki Yamane Yuka
    Ohira, Masahiro
    Tahara, Hiroyuki
    Ide, Kentaro
    Ohdan, Hideki
    TRANSPLANTATION, 2020, 104 (09) : S160 - S160
  • [27] PREDICTED INDIRECTLY RECOGNIZABLE HLA EPITOPES PRESENTED BY HLA-DR CORRELATE WITH THE DE NOVO DEVELOPMENT OF DONOR-SPECIFIC HLA IGG ANTIBODIES AFTER KIDNEY TRANSPLANTATION
    Otten, Henny G.
    Calis, Jorg
    Kesmir, Can
    van Zuilen, Arjan D.
    Spierings, Eric
    TISSUE ANTIGENS, 2013, 81 (05): : 273 - 274
  • [28] Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation
    Otten, Henny G.
    Calis, Jorg J. A.
    Kesmir, Can
    van Zuilen, Arjan D.
    Spierings, Eric
    HUMAN IMMUNOLOGY, 2013, 74 (03) : 290 - 296
  • [29] Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk
    Maral Baghai Arassi
    Laura Gauche
    Jeremy Schmidt
    Britta Höcker
    Susanne Rieger
    Caner Süsal
    Burkhard Tönshoff
    Alexander Fichtner
    Pediatric Nephrology, 2022, 37 : 2503 - 2514
  • [30] Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk
    Arassi, Maral Baghai
    Gauche, Laura
    Schmidt, Jeremy
    Hoecker, Britta
    Rieger, Susanne
    Suesal, Caner
    Toenshoff, Burkhard
    Fichtner, Alexander
    PEDIATRIC NEPHROLOGY, 2022, 37 (10) : 2503 - 2514